Abstract
In the airway, gastrointestinal tract, renal parenchyma, and during some clinical situations, basophils and mast cells are exposed to a hyperosmolar milieu. We have shown that hyperosmolar stimuli release pharmacologically active mediators and that the process is distinct from IgE-dependent release. Significant mast cell histamine release occurs at just above physiologic levels (360 mOsm) and reaches a maximum of 12±1% at 770 mOsm; release from basophils is significant at 560 mOsm and reaches a maximum of 45±7% at 1020 mOsm. Activation of mast cells is dependent on extracellular Ca++ but maximal release from basophils is only partially reduced in Ca++ free buffers. Hyperosmolar buffers also increase IgE-dependent histamine release synergistically (mast cells: 460 mOsm 7±1% release; 1 μg/ml anti IgE 7±1%; both 27±4%). Prostaglandin D2 (PGD2) production from mast cells at 770 mOsm (69 pg/100 μ1) was not different from unstimulated cells (83 pg/100 μ1) despite significant histamine release (16% vs. 4% control). Furthermore, IgE-dependent PGD2 production (264 pg/100 μ1) was suppressed (99 pg/100 μ1) in hyperosmolar buffers (p<0.01). The distinctive activation by hyperosmolarity and its interaction with IgE-dependent activation may have important implications for airway physiology, and the management of radiocontrast anaphylactoid reactions and clinical hyperosmolarity syndromes.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eggleston, P., Sobotka, A., Franklintadkinson, N. et al. HYPEROSMOLAR MEDIATOR RELEASE FROM HUMAN BASOPHILS AND MAST CELLS. Pediatr Res 18 (Suppl 4), 254 (1984). https://doi.org/10.1203/00006450-198404001-00969
Issue Date:
DOI: https://doi.org/10.1203/00006450-198404001-00969